https://www.selleckchem.com/pr....oducts/d-luciferin.h
We read with great interest the work by Gragnani et al. on hematological and genetic markers in patients with persisting cryoglobulinemic vasculitis (CV) after achieving sustained virological response with directly acting antivirals (DAAs).1 The authors have touched upon an essential aspect of holistic HCV care often overlooked in the HCV success story. Biliary tract cancer (BTC) exhibits diverse molecular characteristics. However, reliable biomarkers that predict therapeutic responses are yet to be discovered. We aimed to identify
Like
Comment
Share
